Stay updated on Sotatercept in ESRD Hemodialysis: Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in ESRD Hemodialysis: Clinical Trial page.

Latest updates to the Sotatercept in ESRD Hemodialysis: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study information regarding the pharmacokinetics and safety of sotatercept (ACE-011) for anemia in hemodialysis patients, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check19 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check77 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check84 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Sotatercept in ESRD Hemodialysis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in ESRD Hemodialysis: Clinical Trial page.